An Alberta-led clinical trial has introduced a simpler way to treat clostridium difficile.
There are about 200 cases of C. Difficile every year in Alberta, of which 20 to 40 are fatal. Up until now, doctors have been using fecal microbiota transplants delivered by colonoscopy to cure the disease.
Fecal microbiota transplants contain a healthy donors stool which restores the healthy balance of bacteria living inside the intestine. The invasive colonoscopy has now been replaced by simple capsules which are proved less invasive, but just as effective. The capsules are taken orally, and have no scent or taste. However, one test subject said she had to take 40 capsules in the span of one hour.
Doctor Dino Kao, the lead author of the study, says the capsule would likely safe the Alberta health system $1000 per patient.